Original news and analysis on international IP policy
Pharmaceutical manufacturer Gilead has given its side to this week's story of the rejection of its patent on a hepatitis C treatment in India, and it insists it will prevail in making its medicines available in India on its terms.
A new industry report explores ways authors, research institutions and publishers are grappling with the increasing move toward open access mandates by governments.
Today's rejection by the Patent Office Controller of India of a patent application by Gilead company for a key drug against hepatitis C is being hailed by advocates as a path to dramatically lower costs of treatment for the disease. Hepatitis C has been noteworthy for exorbitantly priced medicines over the past year. A look at the decision shows that a provision in India's law continues to stop patent applications if they fail to show sufficient novelty and inventive step - and are subject to opposition.
The first draft of a national intellectual property rights policy being developed by a “think tank” of Indian IP experts shows adherence to the country’s principles of bending the IP system to its local needs. But it also shows signs of major change toward more international goals of enforcement and promotion of strong IP rights.
All year long, Intellectual Property Watch expends great energy and resources to bring hundreds of carefully written, detailed stories on policymaking - technical committee meetings, legislation, negotiations, legal cases, and latest reports and papers. But in what is perhaps typical of readers everywhere, many of the best-read IP-Watch stories of 2014 were those few that involved elections and personnel issues and India, followed by a range of hot button issues such as high-priced medicines, copyright and knowledge access, patent valuation, or internet surveillance.
The European Copyright Society, an august group of copyright experts from across Europe, has issued a letter to new European Commissioner for Digital Economy and Society Günther Oettinger supporting his mandate to pursue copyright reform and calling for a unification of European copyright laws.
WASHINGTON, DC – Last week was ‘old home week’ for officials in the United States intellectual property attaché program, as they returned before the holidays from their posts around the world. Speaking publicly, the officials gave mixed reports on the fight to advance IP rights worldwide. They also heard harsh but determined words about the situation in Geneva from the industry perspective. Two more attaché offices will open next year, and several attachés last week called for an elevation in their rank in order to enable them to have access to higher level officials in other countries.
The United States and China yesterday concluded a three-day high-level meeting with numerous outcomes on intellectual property rights, including: local treatment of IP, trade secrets, geographical indications, inventor rights, patent data, sales of IP-intensive goods and services, online infringement, treatment of IP in standard-setting, bad-faith trademark filings, judicial best practices, and licensing of technology, according to the United States.
China has been filing patents at far greater rates than any other nation on earth in recent years. This week, a Thomson Reuters report broke down that growth and compared it with other leading nations on the basis of innovation.
The Vienna-based United Nations Office on Drugs and Crime (UNODC) has been working for several years to fight “fraudulent” medicines in the global supply chain. But an alleged new draft model legislation it is developing includes intellectual property rights, an issue which has led to intensive debates in other international fora. This week, a closed-door UNODC informal expert group drafting the model legislation is meeting in Vienna.
Last week’s United Nations draft report for the post-2015 sustainable development goals under negotiation calls for continued progress toward sweeping improvements in the lives of all people and the health of the planet, including ensuring that intellectual property rights are respected but do not get in the way.
From EDRi: Ville Oksanen, Vice President and a founding member of Electronic Frontier Finland (Effi), passed away on Sunday 23 November 2014 in Helsinki from a sudden illness. He was 37 years old.